Urgent.News

What's breaking now, across thousands of outlets.

More in Tech

Celltrion Expands Brazil Portfolio to 10 Products with New Treatments

Celltrion is accelerating its expansion in Brazil with the launch of new treatments for autoimmune and bone diseases, strengthening its product portfolio and leveraging its existing sales network in…

  • Celltrion adds 3 new treatments to Brazil portfolio, expanding to 10 products
  • Introduces Coivolma (ustekinumab), Stoboclo (denosumab), and Osenvelt (denosumab)
  • Formulations aim to give physicians more prescribing flexibility and patient options

More from Thursday 5 November →